... Wace North America L.P. bought a new position in CymaBay Therapeutics during the 2nd quarter worth $242,000. Ardsley Advisory Partners grew its stake in CymaBay Therapeutics by 66.2% during the 2nd quarter. Ardsley Advisory Partners now owns 50,210 ...
http://ift.tt/2zmZenx
No comments:
Post a Comment